Photo of Dr Gordon Ingle

Dr Gordon Ingle

Telephone:

Email:

Location:

  • National Hospital for Neurology and Neurosurgery

GMC/GDC number:

4119728

Professional background

I qualified in Medicine at the University of Edinburgh with a First Class Honours Degree in Neuroscience and worked in Scotland and Yorkshire before coming to London to work in the Institute of Neurology as a Research fellow in 1999. I obtained my MD from the University of London working With Professor Alan Thompson on a long term study looking at magnetic resonance imaging markers in Primary Progressive Multiple Sclerosis. I completed my specialist training in London and the South East and have worked as a consultant neurologist at both Whipps Cross Hospital and at The National Hospital for Neurology and Neurosurgery, Queen Square, since 2008. I have a strong interest in General Neurology and my sub-speciality interests are in Autonomic Neurology and Multiple Sclerosis. I run general neurology clinics at both Whipps Cross and NHNN and take a leading role in the specialist Autonomic Neurology Service at NHNN along with my colleagues, Dr Iodice and Dr Hagen.

I am also clinical lead for neurology at Whipps Cross University Hospital.

Specialties

Research interests

My primary research was in multiple scleorsis, but while retaining an interest in this area I have become increasingly involved in supporting autonomic research as a consultant in the NHNN Autonomic Unit. The special interests of that service include, autoimmune autonomic neuropathy, spinal injury, multiple system atrophy and the postural tachycardia syndrome.

Publications

  • Primary progressive multiple sclerosis: a 5-year clinical and MR study. Ingle GT, Stevenson VL, Miller DH, Thompson AJ. Brain. 2003 Nov;126(Pt 11):2528-36
  • Two-year follow-up study of primary and transitional progressive multiple sclerosis. Ingle GT, Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, Brochet B, Dousset V, Filippi M, Montalban X, Kalkers NF, Polman CH, Rovira A, Thompson AJ. Mult Scler. 2002 Apr;8(2):108-14.
  • Magnetic resonance imaging in primary progressive multiple sclerosis. Ingle GT, Thompson AJ, Miller DH. Rehabil Res Dev. 2002 Mar-Apr;39(2):261-7
  • Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit Davies G, Irani SR, Coltart C, Ingle G, Amin Y, Taylor C, Radcliffe J, Hirsch NP, Howard RS, Vincent A, Kullmann DM. Crit Care Med. 2010 Feb;38(2):679-82
  • Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure. Healy DG, Ingle GT, Brown P.Mov Disord. 2009 Oct 15;24(13):2028-9
  • Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Sepulcre J, Sastre-Garriga J, Cercignani M, Ingle GT, Miller DH, Thompson AJ. Arch Neurol. 2006 Aug;63(8):1175-80
  • Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. Bieniek M, Altmann DR, Davies GR, Ingle GT, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH. J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1036-9
  • Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study Ramió-Torrentà L, Sastre-Garriga J, Ingle GT, Davies GR, Ameen V, Miller DH, Thompson AJ. J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):40-5
  • Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. Karrenbauer VD, Leoni V, Lim ET, Giovannoni G, Ingle GT, Sastre-Garriga J, Thompson AJ, Rashid W, Davies G, Miller DH, Björkhem I, Masterman T. Clin Neurol Neurosurg. 2006 Jul;108(5):456-60
  • Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data Sastre-Garriga J, Ingle GT, Rovaris M, Téllez N, Jasperse B, Altmann DR, Benedetti B, Stevenson VL, Cercignani M, Leary SM, Barkhof F, Brochet B, Dousset V, Filippi M, Montalban X, Kalkers NF, Polman CH, Rovira A, Miller DH, Thompson AJ. Neurology. 2005 Aug 23;65(4):633-5.
  • Is inflammation important in early PPMS? a longitudinal MRI study.Ingle GT, Sastre-Garriga J, Miller DH, Thompson AJ. J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1255-8
  • A longitudinal study of cognition in primary progressive multiple sclerosis Camp SJ, Stevenson VL, Thompson AJ, Ingle GT, Miller DH, Borras C, Brochet B, Dousset V, Falautano M, Filippi M, Kalkers NF, Montalban X, Polman CH, Langdon DW. Brain. 2005 Dec;128(Pt 12):2891-8
  • Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, McLean MA, Miller DH, Thompson AJ. Arch Neurol. 2005 Apr;62(4):569-73.
  • Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal studySastre-Garriga J, Ingle GT, Chard DT, Cercignani M, Ramió-Torrentà L, Miller DH, Thompson AJ. Brain. 2005 Jun;128(Pt 6):1454-60.
  • Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study Stevenson VL, Ingle GT, Miller DH, Thompson AJ. Mult Scler. 2004 Aug;10(4):398-401.
  • Abnormalities of cerebral perfusion in multiple sclerosis Rashid W, Parkes LM, Ingle GT, Chard DT, Toosy AT, Altmann DR, Symms MR, Tofts PS, Thompson AJ, Miller DH. J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1288-93. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, Miller DH, Thompson AJ. Neuroimage. 2004 May;22(1):353-9.
  • Magnetic resonance imaging and single photon emission tomography in treatment-responsive and treatment-resistant schizophrenia. Lawrie SM, Ingle GT, Santosh CG, Rogers AC, Rimmington JE, Naidu KP, Best JJ, O'Carroll Re, Goodwin GM, Ebmeier KP, et al. Br J Psychiatry. 1995 Aug;167(2):202-10